Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 1,696	$ 91,407
Prepaid expenses	143,687	208,056
Total Current Assets	145,383	299,463
Marketable securities held in Trust Account	230,278,727	230,021,238
TOTAL ASSETS	230,424,110	230,320,701
Current liabilities:
Accrued expenses	3,168,026	312,942
Advances from related parties	3,370	870
Promissory note – related party	149,980
Total Current Liabilities	3,321,376	313,812
Warrant liabilities	1,540,169	18,505,400
Deferred underwriting commission payable	8,650,000	8,650,000
Total Liabilities	13,511,545	27,469,212
Commitments and Contingencies
Class A ordinary shares subject to possible redemption, 23,000,000 shares at redemption value at June 30, 2022 and December 31, 2021	230,278,727	230,021,238
Shareholders’ Deficit
Preference shares, $0.0001 par value; 5,000,000 shares authorized; no shares issued and outstanding at June 30, 2022 and December 31, 2021
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 5,750,000 shares issued and outstanding, at June 30, 2022 and December 31, 2021	575	575
Additional paid-in capital
Accumulated deficit	(13,366,737)	(27,170,324)
Total Shareholders’ Deficit	(13,366,162)	(27,169,749)
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT	$ 230,424,110	$ 230,320,701

No definition available.

Name:	biot_WarrantLiabilitiesValue
Namespace Prefix:	biot_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.